Advertisement

Topics

MedinCell Boosts Funding For Long-Acting Injectables Portfolio

08:00 EDT 12 Oct 2018 | SCRIP

France's long-acting injectables technology company, MedinCell, which is collaborating with Teva on a Phase III long-acting risperidone formulation, has completed...

      

Related Stories

 

Original Article: MedinCell Boosts Funding For Long-Acting Injectables Portfolio

NEXT ARTICLE

More From BioPortfolio on "MedinCell Boosts Funding For Long-Acting Injectables Portfolio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...